Education
About Us
Working with TipRanks
Follow Us
Dynavax Technologies (DVAX)
:DVAX
Rf1v-1018
Prevention Of Pneumonic Plague Resulting From Aerosol Exposure To Yersenia Pestis
Phase II
Recruiting
Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55 Years of Age
Oct 02, 2025
―
Rf1v-1018, Rf1v Vaccine
Vaccine-Preventable Diseases, Plague, Pneumonic, Plague
Phase II
Completed
Trial of the Immunogenicity, Safety, and Tolerability of rF1V Vaccine With CpG 1018® Adjuvant Compared With rF1V Vaccine in Adults 18 to 55 Years of Age
Aug 10, 2022
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Dynavax Technologies (DVAX) have in its pipeline
DVAX is currently developing the following drugs: Rf1v-1018, Rf1v-1018, Rf1v Vaccine. These drug candidates are in various stages of clinical development as the company works toward FDA approval.